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Tissue Doppler imaging is a sensitive
echocardiographic technique to detect
subclinical systolic and diastolic
dysfunction of both ventricles in type 1
diabetes mellitus
David Suran1*, Andreja Sinkovic2 and Franjo Naji1
Abstract
Background: Subclinical left (LV) and right ventricular (RV) dysfunction has been demonstrated in type 2 diabetes
mellitus and evidence indicates impaired LV diastolic function in type 1 diabetes mellitus (T1DM) as well. The aim of
our study was to evaluate the role of tissue Doppler imaging (TDI) in assessment of global LV and RV function in
T1DM patients.
Methods: A detailed two-dimensional, pulsed wave Doppler and pulsed wave TDI analysis was performed in 53
normotensive middle-aged T1DM patients and compared to healthy controls.
Results: In T1DM patients TDI analysis revealed reduced mean mitral septal and lateral E’ velocities as well as
reduced mean tricuspid E˙t velocity compared to healthy controls (E’sept 8.89 ± 1.89 cm/s vs. 11.50 ± 2.41 cm/s,
p < 0.001; E’lat 12.29 ± 2.58 cm/s vs.15.30 ± 2.95 cm/s, p < 0,001; E’t 13.56 ± 2.91 cm/s vs. 15.60 ± 2.99 cm/s, p = 0.001).
Mean ratios E/E’sept, E/E’lat and E/E’t were significantly higher in diabetics with cutoff value of 7.4 for E/E’sept and
3.4 for E/E’t, differentiating diabetics with LV and RV diastolic impairement from matched healthy controls (sensitivity
76.5 %, specificity 73.8 % for E/E’sept and sensitivity 72.1 %, specificity 66.7 % for E/E’t). Myocardial acceleration during
isovolumetric contraction (IVA) measured at the septal mitral (LV IVA) and lateral tricuspid annulus (RV IVA) was the
only parameter indicating reduced contractility of both ventricles in diabetics compared to controls (LV IVA 230.70 ±
61.26 cm/s2 vs. 283.32 ± 59.74 cm/s2, p < 0,001; RV IVA 275.48 ± 68.08 cm/s2 vs. 316.86 ± 80.95 cm/s2, p = 0.011). LV IVA
had better diagnostic accuracy than RV IVA to predict early contractile impairement in T1DM patients (area under the
curve 0.758, p < 0.001 for LV IVA and 0.648, p = 0.017 for RV IVA).
Conclusions: TDI is essential to detect subclinical diastolic deterioration of both ventricles in T1DM patients. TDI-derived
IVA might be useful to assess early systolic alterations of both ventricles in T1DM patients.
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Background
Patients with diabetes mellitus (DM) have high incidence
of heart failure [1, 2]. DM promotes myocardial damage
even in the absence of hypertension, valvular or ischemic
heart disease and the condition has been characterised
as diabetic cardiomyopathy [1–3].
Most echocardiographic studies have been performed
in populations with type 2 diabetes mellitus (T2DM),
while in type 1 DM (T1DM) patients the developement
of left ventricular (LV) and right ventricular (RV) dys-
function has been much less studied [4–6]. Recently, a
large observational study has documented a high degree
of LV diastolic dysfunction in T1DM patients, while data
on RV diastolic dysfunction in this population are lim-
ited [7]. Impact of T1DM on development of LV and RV
systolic dysfunction is controversial – very recent tissue
deformation studies revealed some evidence of LV and
RV contractile impairement, while the majority of prior
studies using conventional echocardiographic parame-
ters or even tissue Doppler imaging (TDI) did not show
the difference [8–12].
The objective of the present study was to evaluate the
potential role of TDI in detection of subclinical global
LV and RV dysfunction in normotensive T1DM patients
without other comorbidities.
Methods
Study design and participants
This was a cross-sectional study, conducted in the Func-
tional Diagnostic Unit of the Department of Cardiology
and Angiology at University Medical Centre Maribor,
Slovenia. The study was approved by the National Med-
ical Ethics Committee of the Republic of Slovenia (Med-
ical Ethics Committee approval number 130/10/13).
Written informed consent was obtained from all the par-
ticipants. The study protocol conformed to the ethical
guidelines of the Declaration of Helsinki.
We enrolled 53 normotensive patients with T1DM
known for more than 5 years (mean age 44.3 ± 5.4 years;
56.6 % men, 43.4 % women). Patients were asymptom-
atic at enrollement and in the past; they had no history
of heart failure or coronary artery disease. They were all
in sinus rhythm.
The control group consisted of 48 healthy volunteers
with mean age of 42.7 ± 6.1 years (56.3 % men and
43.7 % women). All patients and healthy subjects were
recruited on the outpatient basis.
Before enrollment all medical records of included
diabetic patients and controls were verified and clin-
ical history obtained. Smoking was documented in
all participants. Detailed clinical examination was
performed in all subjects, including measurements of
blood pressure twice in supine position, body height
and weight to calculate body mass index (BMI).
Electrocardiogram (ECG) was recorded in supine
position.
Exclusion criteria were age above 53 and below
33 years, arterial hypertension, duration of T1DM less
than 5 years, ischaemic heart disease (evaluated by
careful consideration of medical history, ECG, echocar-
diographic assessment of regional LV wall motion abnor-
malities), overt left ventricular systolic dysfunction-left
ventricular ejection fraction (LVEF) < 50 %, bundle
branch block, more than mild valvular regurgitations
and valvular stenosis of any degree, cardiomyopathies
(dilatative, hypertrophic, restrictive), congenital heart
diseases, arrhythmias, chronic pulmonary disease, pul-
monary hypertension, untreated thyroid disease, sys-
temic connective tissue diseases, pregnancy, extreme
obesity (BMI above 35), advanced diabetic nephropathy
(glomerular filtration rate below 60 ml/min), low quality
echocardiographic image. The same exclusion criteria
were used for both groups.
Laboratory measurements
Before echocardiographic examination blood samples
were drawn in patients with T1DM to measure serum
creatinine, lipid profile and glycosylated hemoglobin
(HbA1c). In addition, all results of HbA1c measure-
ments in the last 5 years were collected – HbA1c
measurements were performed in the diabetes
outpatient clinic of our institution at regular 6-month
follow-up.
Serum creatinine was measured by IDMS-traceable
enzymatic assay (Siemens Healthcare Diagnostics Inc.,
Newark, USA; normal levels 44–97 μmol/l) [13].
The lipid profile consisted of serum triglycerides,
total serum cholesterol, LDL and HDL cholesterol.
Triglycerides were measured the by the enzymatic
method (Siemens Healthcare Diagnostics Inc., Newark,
USA; normal levels 0.6–1.7 mmol/L) and total serum
cholesterol by the cholesterol esterase enzymatic assay
(Siemens HealthCare Diagnostics Inc., Newark, USA);
high density lipoproteins (HDL) and low density lipopro-
teins (LDL) were measured by the homogenous direct
method (Siemens Healthcare Diagnostics Inc., Newark,
USA) [13].
HbA1c was measured by the ion-exchange high
performance liquid chromatography (Bio-Rad Laboratories,
USA; normal levels 4.0–6.0 %) [13].
The degree of albuminuria was assessed in the second
morning urine sample by the nephelometric method
(Siemens HealthCare Diagnostics Inc., Newark, USA)
and expressed as urine albumin-to-creatinine ratio
(UACR, normal levels below 30 mg albumin/g creatinine).
Albuminuria was defined as UACR ≥ 30 mg albumin/g
creatinine [13].
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Echocardiography
All echocardiographic examinations were performed by
a single experienced echocardiographer on the same
ultrasound machine (iE33, Philips Medical Systems) at
the same institution. A detailed two-dimensional (2D),
pulsed wave Doppler (PWD) and pulsed wave TDI
(pwTDI) analysis of the LV and RV were performed.
Color Doppler recordings were obtained to exclude
valvular dysfunction. All measurements were performed
on the basis of the American Society of Echocardiog-
raphy and European Association of Cardiovascular Im-
aging recommendations [14–16].
The maximal end-systolic volume of the left atrium
(LA) was measured by the 2D biplane area-length for-
mula and indexed to body surface area (BSA). Right
atrial (RA) area was measured in four-chamber view and
indexed to BSA. Modified biplane Simpson’s method
was used to determine LVEF.
Mitral and tricuspid inflow velocities were evaluated
by PWD from the apical four-chamber view and the fol-
lowing parameters were measured: peak early mitral in-
flow velocity (E), peak late mitral inflow velocity (A), E/
A ratio, deceleration time of the E velocity (DT). From
the tricuspid inflow pattern we measured peak early (Et)
and late (At) diastolic velocity, Et/At ratio and deceler-
ation time (DT-t).
PwTDI recordings were acquired from the apical four-
chamber view and were used to measure peak myocardial
systolic an diastolic velocities at the septal (S’sept, E’sept,
A’sept) and lateral corner (S’lat, E’lat, A’lat) of the mitral
annulus and peak myocardial systolic and diastolic veloci-
ties at the lateral tricuspid annulus (S’t, E’t, A’t). PwTDI-
derived peak myocardial velocity during isovolumetric
contraction (IVV) (cm/s) was measured at the septal mi-
tral (LV IVV) and lateral tricuspid annulus (RV IVV).
Myocardial acceleration during isovolumetric contraction
(IVA) (cm/s2) was calculated for both ventricles (LV IVA
and RV IVA) as the ratio of IVV devided by the acceler-
ation time (AT), which was defined as the time spent from
baseline to the peak velocity of isovolumetric contraction.
The LV and RV myocardial performance index (MPI)
was assessed by pwTDI and calculated as the sum of the
isovolumetric contraction time and isovolumetric relax-
ation time divided by ventricular ejection time.
All Doppler parameters except IVV and AT were re-
corded at a sweep speed of 75 mm/s at end expiration,
while IVV and AT were recorded at a speed of 150 mm/
s. The average value of three consecutive cardiac cycles
was considered in statistical analysis. Settings were ad-
justed for a frame rate of above 150 Hz.
Statistical analysis
SPSS Statistics 22.0 (IBM Corp., Armonk, New York,
USA) was used for statistical analysis. The Shapiro–Wilks
test was used to confirm normal distribution of data for
all variables. Categorical variables were presented as per-
centages and compared with two-tailed Fisher’s exact test.
Normally distributed continuous variables were presented
as mean ± standard deviation and compared with unpaired
Student’s t-test. The correlations between continuous
variables were assessed with the Pearson’s correlation co-
efficient (r). P < 0.05 was considered statistically signifi-
cant. Also, we performed receiver operating characteristic
(ROC) curve analysis of LV IVA, LVEF, RV IVA, E/E’sept,
E/E’t, LA volume index and RA area index to select opti-
mal cutoff values based on equally balanced sensitivity
and specificity to detect early LV and RV impairement in
diabetic patients.
To assess intraobserver variability a TDI dataset of 16
randomly selected participants was analyzed for LV IVV,
LV IVA, RV IVV and RV IVA by the same observer on
two different days. For interobserver variability assess-
ment a second observer blinded to the clinical informa-
tion and to the results of the first observer analyzed the
same TDI recordings. Variability was calculated in two
ways: a) as the mean percent error, derived as the differ-
ence between two measurements, divided by the mean
value of these two measurements and b) by intraclass
correlation coefficients (ICC) for absolute agreement.
Results
Clinical characteristics and laboratory data
Ninety-seven T1DM patients treated at our diabetes out-
patient clinic met inclusion criteria and were invited to
participate in the study. Thirty-four patients refused to
join the study and ten patients were later excluded
because of poor echocardiographic image quality or
valvular abnormalities. Finally, fifty-three T1DM patients
were enrolled to the study.
Demographic and clinical data are presented in Table 1.
There was no difference in age, gender, BSA, BMI, blood
pressure and smoking between the two groups. Mean
diabetes duration was 18.2 ± 7.2 years. All diabetic pa-
tients were treated with insulin; 45.3 % of patients used
an insulin pump and 44.7 % of them were on standard
insulin regimen.
Laboratory data are presented in Table 2. Mean
HbA1c level was 7.6 ± 1.1 at the time of enrollment.
Mean value of HbA1c in the last 5 years was 7.2 ± 0.8.
Serum creatinine was normal in all patients. Albumin-
uria was detected in only one patient (1.9 %) and mean
UACR was 6.5 ± 5.4.
Echocardiography data
Standard echocardiographic measurements, PWD and
TDI-derived data are summarised in Table 3. In T1DM
patients in comparison to healthy controls we observed
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significantly increased LA volume index and RA area
index (Table 3).
Regarding LV echocardiographic measurements, in
T1DM patients we observed significantly increased in-
terventricular septal (IVS) and LV posterior wall (LVPW)
thickness, but equal values of end diastolic LV dimen-
sion (LVIDd) and LVEF in comparison to healthy con-
trols (Table 3).
Regarding right ventricular dimensions (RVD1, RVD1
index, RVD2, RVD3) and TAPSE we did not observe any
significant difference in T1DM patients compared to
healthy controls (Table 3).
Although mean levels of mitral and tricuspid PWD
parameters were still within normal in both groups
according to guidelines [14–16], mean peak late mitral
(A) and tricuspid (At) inflow velocities were significantly
increased in T1DM patients, while mitral (E/A) and tri-
cuspid (Et/At) ratios were significantly decreased in
T1DM patients in comparison to controls. Mitral DT
was significantly prolonged in T1DM patients compared
to control group (Table 3).
TDI findings
TDI findings in T1DM patients compared to controls
showed significantly decreased diastolic mitral annular
velocities (E’sept, E’lat), significantly lower ratios E’/
A’sept and E’/A’lat, significantly increased ratios E/E’sept,
E/E’lat, significantly decreased S’sept, while the differ-
ence in S’lat was nonsignificant between T1DM patients
and controls. LV IVA was significantly reduced in
T1DM group compared to controls, while there was no
significant difference in LV IVV between the groups
(Table 3).
E’t was significantly decreased in T1DM patients while
S’t was similar between the groups. The ratio E/E’t was
significantly increased and E’/A’t was significantly de-
creased in diabetics in comparison to controls. RV IVV
and RV IVA were both significantly reduced in diabetics
compared to controls (Table 3).
We did not observe any significant difference in LV
MPI and RV MPI between the groups (Table 3).
Receiver operating characteristic curves analysis
ROC curves of systolic parameters (LV IVA, LVEF and
RV IVA) are presented in Fig. 1. LV IVA provided the
highest area under the curve (AUC) to detect early LV
contractile dysfunction in diabetics (AUC 0.758, 95 % CI
0.648–0.869). Values of LV IVA below the cutoff point of
240 cm/s2 were characteristic for diabetics with 69.2 %
sensitivity and 63.0 % specificity (p < 0.001). LVEF was
not useful to predict early LV contractile impairement in
diabetics (AUC 0.59, 95 % CI 0.455–0.725, p = 0.205).
RV IVA below 295 cm/s2 was characteristic to detect
early RV systolic dysfunction in diabetics (AUC 0.648,
95 % CI 0.533–0.763, p = 0.017), but sensitivity and spe-
cificity were very low (54.6 and 56.8 %, respectively).
ROC curves of diastolic parameters (E/E’sept, E/E’t,
RA area index and LA volume index) are presented in
Fig. 2. LA volume index and RA area index showed the
highest AUC (AUC of LA volume index 0.923, 95 % CI
0.867–0.978, p < 0.001 and AUC of RA area index 0.833,
95 % CI 0.744–0.923, p < 0.001) to detect diabetics with
early LV and RV diastolic impairement compared to
healthy controls with the cutoff value of 26.0 ml/m2 for
LA volume index (sensitivity 82.4 %, specificity 83.3 %)
and 7.2 cm2/m2 for RA area index (sensitivity 74.4 %,
specificity 78.8 %). Diagnostic accuracy of E/E’sept and
E/E’t was also high (AUC of E/E’sept 0.857, 95 % CI
0.782–0.933, p < 0.001, AUC of E/E’t 0.722, 95 % CI
0.606–0.838, p = 0.001). Values above 7.4 for E/E’sept
(sensitivity 76.5 %, specificity 73.8 %) and 3.4 for E/E’t
(sensitivity 72.1 %, specificity 66.7 %) were characteristic
for diabetic patients.
Correlation analysis between LV / RV systolic function
assessed by LV IVA/RV IVA and clinical, laboratory,
echocardiographic parameters in diabetic patients
In T1DM patients moderate but statistically significant
correlations were found between LV IVA and E/E’lat
(r = −0.38, p = 0.008) and S’lat (r = 0.316, p = 0.027).









Age (years) 44.3 ± 5.4 42.7 ± 6.1 0.159
Gender (male/female, %) 56.6/43.4 56.3/43.7 0.873
Body mass index (kg/m2) 27.0 ± 4.0 25.6 ± 3.5 0.068
Body surface area (m2) 1.94 ± 0.2 1.90 ± 0.2 0.430
Smoking (%) 24.5 33.3 0.454
Systolic blood pressure (mmHg) 126.0 ± 9.5 123.0 ± 10.7 0.168
Diastolic blood pressure (mmHg) 79.5 ± 5.8 77.0 ± 7.0 0.061
Table 2 Laboratory data of diabetic patients (n = 53)
Variable Mean ± SD
HbA1c (at enrollment, %) 7.6 ± 1.1
HbA1c (5-year average, %) 7.2 ± 0.8
Serum creatinine (μmol/L) 69.6 ± 12.6
UACR (mg albumin/g creatinine) 6.5 ± 5.4
Total cholesterol (mmol/L) 4.9 ± 0.8
HDL (mmol/L) 1.8 ± 0.5
LDL (mmol/L) 2.9 ± 0.8
Triglycerides 0.9 ± 0.5
SD standard deviation, HbA1c glycosylated hemoglobin, UACR urinary albumin-
to-creatinine ratio, HDL high density lipoprotein, LDL low density lipoprotein
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Table 3 Echocardiographic data of diabetic and control subjects
Diabetic partients (n = 53) Healthy controls (n = 48) p-value
LA/RA dimensions (mean ± SD)
LA volume (ml) 57.78 ± 11.15 43.89 ± 7.97 <0.001
LA volume/BSA (ml/m2) 29.44 ± 3.82 22.94 ± 3.25 <0.001
RA area (cm2) 15.38 ± 2.15 12.69 ± 2.05 <0.001
RA area/BSA (cm2/m2) 7.90 ± 0.95 6.61 ± 0.79 <0.001
LV dimensions (2D), LVEF (mean ± SD)
IVS (cm) 0.92 ± 0.11 0.82 ± 0.09 <0.001
LVIDd (cm) 4.61 ± 0.39 4.65 ± 0.42 0.638
LVIDd/BSA (cm/m2) 2.38 ± 0.24 2.46 ± 0.21 0.106
LVPW (cm) 0.93 ± 0.11 0.85 ± 0.09 <0.001
LVEF (%) 66.57 ± 5.89 67.82 ± 5.08 0.324
RV dimensions (2D) and TAPSE (mean ± SD)
RVD1 (cm) 3.49 ± 0.37 3.53 ± 0.94 0.786
RVD1/BSA (cm/m2) 1.79 ± 0.21 1.87 ± 0.44 0.262
RVD2 (cm) 2.72 ± 0.43 2.60 ± 0.38 0.211
RVD3 (cm) 7.10 ± 0.88 7.1 ± 0.82 0.977
TAPSE (cm) 2.73 ± 0.36 2.83 ± 0.26 0.154
Mitral PWD parameters (mean ± SD)
E (m/s) 0.79 ± 0.16 0.74 ± 0.12 0.111
A (m/s) 0.68 ± 0.13 0.58 ± 0.10 <0.001
E/A 1.19 ± 0.25 1.33 ± 0.27 0.011
DT (ms) 187.76 ± 45.1 163.56 ± 28.14 0.002
Tricuspid (t) PWD parameters (mean ± SD)
Et (m/s) 0.52 ± 0.11 0.49 ± 0.07 0.208
At (m/s) 0.44 ± 0.22 0.35 ± 0.06 0.007
Et/At 1.27 ± 0.31 1.41 ± 0.24 0.015
DT-t (ms) 214.26 ± 65.41 210.61 ± 48.87 0.796
LV TDI parameters (mean ± SD)
S’ sept (cm/s) 8.46 ± 1.64 9.19 ± 1.19 0.012
S’ lat (cm/s) 10.62 ± 2.23 11.22 ± 2.29 0.183
E’ sept (cm/s) 8.89 ± 1.89 11.50 ± 2.41 <0.001
A’ sept (cm/s) 9.74 ± 1.95 9.41 ± 1.68 0.378
E’/A’ sept 0.94 ± 0.26 1.28 ± 0.42 <0.001
E/E’sept 9.07 ± 1.86 6.65 ± 1.35 <0.001
E’ lat (cm/s) 12.29 ± 2.58 15.30 ± 2.95 <0.001
A’ lat (cm/s) 9.64 ± 1.97 9.17 ± 2.45 0.296
E’/A’ lat 1.35 ± 0.48 1.81 ± 0.64 <0.001
E/E’ lat 6.55 ± 1.16 4.96 ± 0.90 <0.001
LV IVV (cm/s) 6.82 ± 2.22 7.18 ± 2.00 0.406
LV IVA (cm/s2) 230.70 ± 61.26 283.32 ± 59.74 <0.001
LV MPI 0.51 ± 0.10 0.49 ± 0.09 0.455
RV TDI parameters (mean ± SD)
S’t (cm/s) 14.40 ± 2.50 14.38 ± 2.15 0.961
E’t (cm/s) 13.56 ± 2.91 15.60 ± 2.99 0.001
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RV IVA correlated with BMI (r = 0.307), but the cor-
relation met only borderline statistical significance (p
= 0.045). No relationship was found between LV IVA
and the following parameters: age, DM duration,
BMI, E’sept, E’lat, E/E’sept, S’sept, S’t, E’t and E/E’t.
Similarly, no correlation was found between RV IVA
and age, DM duration, S’t, E’t, E/E’t, S’lat, S’sept, E/
E’sept and E/E’lat. Furthermore, no correlations were
confirmed between LV IVA/RV IVA and parameters
of long-term glycemic control (HbA1c at enrollment
and average HbA1c in the last 5 years). We found no
correlation between LV IVA/RV IVA and other la-
boratory parameters (serum creatinine, total choles-
terol, HDL, LDL, triglycerides, UACR) (Table 4).
Observer variability
Intraobserver variabilities for LV IVV, LV IVA, RV IVV
and RV IVA were 6.84 % (95 % CI 4.71–9.05), 7.22 %
(95 % CI 5.46–9.22), 6.6 % (95 % CI 4.72–8.66) and
8.31 % (95 % CI 6.76–9.96), respectively. Interobserver
variabilities for the corresponding measurements were
5.12 % (95 % CI 4.01–6.12), 11.54 (95 % CI 10.17–
12.92), 5.05 % (95 % CI 4.11–5.96) and 9.70 % (95 % CI
8.49–10.82). ICC for intraobserver variability of LV IVV,
LV IVA, RV IVV, RV IVA was 0.953 (95 % CI 0.871–
0.983), 0.976 (95 % CI 0.933–0.992), 0.953 (95 % CI
0.872–0.983) and 0.958 (95 % CI 0.886–0.985), respect-
ively. ICC for interobserver variabilty of the correspond-
ing measurements was 0.987 (95 % CI 0.962–0.995),
0.946 (95 % CI 0.854–0.981), 0.986 (95 % CI 0.961–
0.995) and 0.952 (95 % CI 0.868–0.983).
Discussion
Our TDI results suggest that in T1DM patients diastolic
function of both ventricles is impaired in comparison to
matched healthy individuals and that there is a possible
systolic impairement of both ventricles in T1DM pa-
tients as assessed by IVA.
Most of our mean PWD and TDI findings were in
normal range for both groups according to current
Table 3 Echocardiographic data of diabetic and control subjects (Continued)
A’t (cm/s) 14.03 ± 3.59 12.09 ± 2.66 0.003
E’/A’t 1.01 ± 0.26 1.35 ± 0.39 <0.001
E/E’t 3.93 ± 1.04 3.27 ± 0.57 <0.001
RV IVV (cm/s) 10.82 ± 2.62 11.98 ± 2.81 0.045
RV IVA (cm/s2) 275.48 ± 68.08 316.86 ± 80.95 0.011
RV MPI 0.31 ± 0.07 0.29 ± 0.07 0.335
LA left atrium, RA right atrium, BSA body surface area, LV left ventricle, LVEF left ventricular ejection fraction, IVS interventricular septum, LVIDd left ventricular internal
dimension at end diastole, LVPW left ventricular posterior wall thickness, RV right ventricle, TAPSE tricuspid anular plane systolic excursion, RVD1 right ventricular basal
diameter, RVD2 right ventricular mid-cavity diameter, RVD3 right ventricular longitudinal diameter; E peak early mitral filling velocity, A peak late mitral filling velocity,
DT peak early mitral velocity deceleration time, Et peak early tricuspid filling velocity, At peak late tricuspid filling velocity, DT-t peak early tricuspid velocity deceleration
time, S’sept peak systolic mitral annular velocity at the septal part of mitral annulus, S’lat peak systolic mitral annular velocity at the lateral part of mitral annulus, E’sept
peak early diastolic mitral annular velocity at the septal part of mitral annulus, E’lat peak early diastolic mitral annular velocity at the lateral part of mitral annulus, A’sept
peak late diastolic mitral annular velocity at the septal part of mitral annulus, A’lat peak late diastolic mitral annular velocity at the lateral part of mitral annulus, S’t peak
systolic tricuspid annular velocity, E’t peak early diastolic tricuspid annular velocity, A’t peak late diastolic tricuspid annular velocity, IVV peak myocardial velocity during
isovolumetric contraction, IVA myocardial acceleration during isovolumetric contraction, MPI myocardial performance index
Fig. 1 Receiver operating characteristic curves of a LV IVA and LVEF, b RV IVA. LV IVA, myocardial acceleration during isovolumetric contraction of
the left ventricle; RV IVA, myocardial acceleration during isovolumetric contraction of the right ventricle; LVEF, left ventricular ejection fraction
Suran et al. BMC Cardiovascular Disorders  (2016) 16:72 Page 6 of 10
guidelines. However, small but statistically significant
differences were detected in diabetics compared to
healthy controls. E’sept, E’lat and E’t were decreased and
E/E’sept, E/E’lat, E/E’t were all increased in diabetic
group compared to controls, indicating worse diastolic
function of both ventricles in this relatively young
T1DM population. Mean LA volume index and mean
RA area were in both groups still in normal range, but
they were significantly higher in diabetics, suggesting
long-term increase of LV and RV filling pressures in
T1DM patients compared to healthy controls.
Recently, in a large observational echocardiographic
study including 1091 T1DM patients (mean age 49.6 years,
53 % men) a high degree (30.8 %) of LV diastolic dysfunc-
tion has been documented among diabetics, which is
more than expected in age-matched nondiabetic popula-
tion [7]; similar prevalence of LV diastolic dysfunction was
reported by Redfield et al. in more than 13 years older
general population [17]. Some other studies including
T1DM patients failed to detect LV diastolic impairement
by PWD and confirmed superiority of TDI in evaluating
subclinical LV diastolic abnormalities [11, 18]. In contrast
to our findings a study of 185 normotensive T1DM pa-
tients and matched healthy controls from 2007 did not
show any significant difference in LV diastolic function be-
tween the two groups neither by conventional echocardi-
ography nor by TDI [6]. A recent study by Fagan et al.
including patients with extremely long duration of T1DM
– more than 50 years – surprisingly documented only
slightly reduced E/A and elevated E/E’sept ratio compared
to controls [19].
Since first published data on RV diastolic dysfunction
in diabetic patients in 2004 [12], only few more studies
have followed. Karamitsos et al. confirmed impaired RV
diastolic function in T1DM patients by reduced tricus-
pid E/A ratio as well as by TDI analysis of E’t compared
to controls, which is consistent with our results [10]. A
study by Khattab et al. including diabetic children and
adolescents demonstrated reduced E’sept and E’t as well
as higher mitral and tricuspid E/E’ratios compared to
matched controls, suggesting some degree of diastolic
impairement of both ventricles in T1DM patients even
at an early age [20].
Limited data exist on potential LV systolic dysfunction
in T1DM patients. Most studies could not demonstrate
LV contractile dysfunction by conventional echocardiog-
raphy nor even by TDI [7, 10, 20].
Data on RV systolic function in T1DM are sparse. First
research on RV contractile function in diabetics was
published by Kosmala et al. in 2004 – they found no dif-
ferences in color TDI-derived longitudinal shortening
velocities of basal and mid segments of the RV free wall
in a non-uniform diabetic group (including both T1DM
and T2DM patients) compared to healthy controls [12].
Similarly, Karamitsos et al. found normal S’t assessed by
pwTDI in T1DM patients [10].
A recent myocardial deformation study based on 2D
speckle tracking echocardiography gave evidence of re-
duced global longitudinal strain of both ventricles in
T1DM patients, while LV global radial strain and LV
twist were not affected significantly [8]. This was in line
with the hypothesis that left ventricular longitudinally
oriented subendocardial fibers are the most vulnerable
and susceptible to metabolic damage [8]. On the other
hand Jensen et al. did not show the difference in LV lon-
gitudinal strain in the absence of albuminuria [21]. Inter-
estingly, in the study by Fagan et al. including patients
with more than 50 years of T1DM no difference was
found in LV longitudinal and circumferential strain,
strain rate and torsion [19].
Our TDI findings give additional evidence of impaired
longitudinal contractility of the LV revealing significantly
reduced S’sept and nonsignificantly reduced S’lat in dia-
betics. On the other hand we could not demonstrate
Fig. 2 Receiver operating characteristic curves of a E/E’sept and LA volume index, b E/E’t and RA area index. LA, left atrium; RA, right atrium
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reduced RV longitudinal shortening neither by TAPSE
nor by S’t, which was consistent with previous reports
[10]. This might be due to the different arrangement of
RV myocardial fibers compared to the LV. The longitu-
dinal RV shortening might be initially preserved in
T1DM, while radial RV displacement has not been
studied yet.
An important finding of our study is the potential of
TDI-derived IVA to assess global systolic function of
both ventricles in T1DM patients. In our study, IVA has
proven to be the only useful TDI-derived parameter to
evaluate potential early systolic impairement of both
ventricles in T1DM patients, though sensitivity and spe-
cificity of RV IVA were low. At present we are not aware
of any other study using this relatively novel TDI-
derived parameter in T1DM population. A similar ability
of IVA to detect LV systolic dysfunction was presented
in a study including T2DM patients, whereas RV con-
tractile dysfunction could not be confirmed by IVA in
this study [22]. IVA was decreased in animal studies in
diabetic rats compared to controls [23].
IVA is supposed to be a robust index of global con-
tractility like dP/dt, as both indices reflect the change of
contractile force during isovolumetric contraction [22].
IVA has been validated as a reliable and relatively load
independent non-invasive measure of RV and LV systolic
function [24–27]. It has been documented as a more
sensitive parameter to assess LV contractility than TDI-
derived peak systolic annular velocity [26]; It has been
successfully applied for research purposes in different
patient populations, including those with heart failure,
valvular heart disease, chronic pulmonary artery disease
and endocrine disorders [28, 29]. Recent studies have
shown reliability of RV IVA in prediction of RV con-
tractile dysfunction after heart valve surgery and its
predictive role in diagnostics of acute pulmonary em-
bolism [26, 30].
Our data show that in diabetics a moderate, but statis-
tically significant positive correlation exists between LV
IVA and S’lat - another parameter of LV contractility.
Furthermore, LV IVA showed a moderate, but significant
negative correlation with E/E’lat. This suggests that sub-
clinical LV systolic and diastolic alterations might de-
velop concurrently in T1DM patients, which has not
been observed till now. However, we did not confirm
these correlations for the RV.
Study limitations
Considering ethical issues we did not perform coronary
angiography to exclude coronary artery disease in our
patients. However, based on detailed medical history all
symptomatic patients with history of exertional angina
or prior myocardial infarction were excluded from the
study. Furthermore, we carefully excluded all patients
with ischemic changes in the resting ECG, echocardio-
graphic LV wall motion abnormalities and LVEF below
50 %. We believe that this limitation did not influence
our results.
Baseline characteristics were not completely balanced,
as diabetic patients had slightly elevated blood pressure
compared to controls, but the difference was not statisti-
cally significant. As 24-h ambulatory blood pressure was
not measured before enrollment, we cannot exclude po-
tential masked hypertension in our patients. However,
blood pressure was regularly checked in diabetic patients
at our diabetes outpatient clinic and detailed medical
hystory of home blood pressure measurements was
taken in all participants before enrollment.
Table 4 Correlation analysis between LV IVA/RV IVA and clical,
laboratory and echocardiographic variables in diabetic patients
Variable LV IVA (n = 53) RV IVA (n = 53)
r p-value r p-value
RV IVA 0.238 0.128
Age (years) −0.127 0.386 0.095 0.545
Duration of diabetes(years) 0.128 0.380 0.011 0.942
BMI (kg/m2) 0.112 0.444 0.307 0.045
HbA1C at enrollment (%) 0.078 0.632 0.068 0.695
HBA1c 5-year average (%) 0.034 0.835 0.124 0.472
Serum creatinine (μmol/L) 0.099 0.538 −0.008 0.964
Total cholesterol (mmol/L) −0.116 0.476 0.122 0.477
Triglycerides (mmol/L) 0.023 0.890 0.094 0.585
HDL (mmol/L) −0.063 0.698 −0,182 0.289
LDL (mmol/L) −0.095 0.560 0.219 0.199
UACR (mg/g) −0.272 0.103 −0.272 0.119
E’sept (cm/s) −0.028 0.851 −0.228 0.142
E’lat (cm/s) 0.089 0.549 −0.129 0.417
E/E’sept −0.191 0.189 −0.080 0.609
E/E’lat −0.380 0.008 −0.199 0.207
S’sept (cm/s) 0.055 0.709 −0.014 0.927
S’lat (cm/s) 0.316 0.027 0.115 0.462
S’t (cm/s) 0.054 0.715 0.291 0.059
E’t (cm/s) −0.065 0.659 0.135 0.388
E/E’t 0.027 0.855 −0.235 0.135
r- Pearson’s correlation coefficient
IVA myocardial acceleration during isovolumetric contraction, BMI body mass
index, HbA1c glycosylated hemoglobin, HDL high density lipoprotein, LDL low
density lipoprotein, UACR urinary albumin-to-creatinine ratio, S’sept peak sys-
tolic mitral annular velocity at the septal part of mitral annulus, S’lat peak
systolic mitral annular velocity at the lateral part of mitral annulus, E’sept peak
early diastolic mitral annular velocity at the septal part of mitral annulus, E’lat
peak early diastolic mitral annular velocity at the lateral part of mitral annulus,
A’sept peak late diastolic mitral annular velocity at the septal part of mitral
annulus, A’lat peak late diastolic mitral annular velocity at the lateral part of
mitral annulus, S’t peak systolic tricuspid annular velocity, E’t peak early diastolic
tricuspid annular velocity, A’t peak late diastolic tricuspid annular velocity
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All echocardiographic measurements were performed
by a single experienced echocardiographer who was not
blinded to the diabetic status of participants. However,
intraobserver and interobserver variabilities of IVV and
IVA measurements were very good, suggesting adequate
reproducibility of our results.
As exclusion criteria were very restrictive the number
of diabetic patients was limited.
Conclusions
PwTDI is a sensitive echocardiographic technique to de-
tect subclinical LV and RV diastolic dysfunction in
T1DM patients. Reduced IVA might be an early indica-
tor of subclinical contractile (systolic) dysfunction of
both ventricles in T1DM patients, though its diagnostic
value is hampered by low sensitivity and specificity.
Further research is warranted to compare the predictive
value of pwTDI-derived LV IVA/RV IVA with 2D and
3D tissue deformation imaging to evaluate potential sub-
clinical LV and RV contractile impairement in this subset
of patients.
Availability of data and materials
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A: peak late mitral inflow velocity; A’lat: peak late diastolic mitral annular
velocity at the lateral part of mitral annulus; A’sept: peak late diastolic mitral
annular velocity at the septal part of mitral annulus; A’t: peak late diastolic
tricuspid annular velocity; At: peak late tricuspid inflow velocity; BSA: body
surface area; DT: deceleration time of peak early mitral inflow velocity; DT-
t: deceleration time of peak early tricuspid inflow velocity; E: peak early mitral
inflow velocity; E’lat: peak early diastolic mitral annular velocity at the lateral
part of mitral annulus; E’sept: peak early diastolic mitral annular velocity at
the septal part of mitral annulus; E’t: peak early diastolic tricuspid annular
velocity; Et: peak early tricuspid inflow velocity; HbA1c: glycosilated
hemoglobin; HDL: high density lipoprotein; IVA: myocardial acceleration
during isovolumetric contraction; IVS: interventricular septum; IVV: peak
myocardial velocity during isovolumetric contraction; LA: left atrium;
LDL: low density lipoprotein; LV: left ventricle; LVEF: left ventricular ejection
fraction; LVIDd: left ventricular internal dimension at end diastole; LVPW: left
ventricular posterior wall; PWD: pulsed wave Doppler; pwTDI: pulsed wave
tissue Doppler imaging; RA: right atrium; RV: right ventricle; RVD1: right
ventricular basal diameter; RVD2: right ventricular mid-cavity diameter;
RVD3: right ventricular longitudinal diameter; S’lat: peak systolic mitral
annular velocity at the lateral part of mitral annulus; S’sept: peak systolic
mitral annular velocity at the septal part of mitral annulus; S’t: peak systolic
tricuspid annular velocity; TAPSE: tricuspid anular plane systolic excursion;
UACR: urinary albumin-to-creatinine ratio.
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